ReBalance Antiprotozoal Oral for Horses
$285.45
ReBalance Antiprotozoal Oral Suspension is indicated for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. Each ml of ReBalance Antiprotozoal Oral Suspension contains 250 mg sulfadiazine and 12.5 mg pyrimethamine. Give 4 ml per 110 lbs. body weight orally once per day. The usual treatment regimen ranges from 90 to 270 days. Sulfadiazine and Pyrimethamine.
ReBalance Antiprotozoal Oral for Horses (sulfadiazine and pyrimethamine)
ReBalance Antiprotozoal Oral for Horses is an oral suspension for horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. EPM is a nervous system disease that horses develop by ingesting contaminated feedstuffs with the protozoa Sarcocystis neurona. EPM presents highly variable clinical signs that may range from head tilt, ear droop, blindness, seizures, inability to chew or swallow, gait abnormalities, stumbling, muscle atrophy, weakness, incoordination, ataxia, or depression. Testing and development of an early, effective treatment plan should be considered.
| Item Number | 178086 |
|---|---|
| Generic Name | Sulfadiazine/Pyrimethamine |
| Common Brand Name(s) | Equisul-SDT, ReBalance |
| For Use With | Horses |
| Administration Form | Oral |
| Product Form | Solution |
| Health Condition | Equine Protozoal Myeloencephalitis (EPM) |
| Drug Type | Antiviral, Antibiotic-Sulfa, Antiprotozoal |
Uses
sulfadiazine and pyrimethamine is indicated for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona.
Side effects may included: Decreased appetite, loose stools, and mild colic.
Prior to treatment with sulfadiazine and pyrimethamine, EPM should be distinguished from the diseases that may cause ataxia in horses. Injuries or lameness may also complicate the evaluation of an animal with EPM. In most instances, ataxia due to EPM is asymmetrical and affects the front and/or the hind limbs.
Treatment may cause generalized bone marrow suppression, anemia, leukopenia, neutropenia and thrombocytopenia. A complete blood count (CBC) should be performed monthly to monitor horses for development of these conditions. The administration of the drug may need to be discontinued and/or treatments for bone marrow suppression initiated.
Worsened neurologic deficits (treatment crisis) may be observed during a period beginning with the first few days of treatment with ReBalance Antiprotozoal Oral Suspension and ranging out to 5 weeks. This neurologic deficit exacerbation may be the result of an inflammatory reaction to the dying parasites in the CNS tissue.
The safe use of ReBalance Antiprotozoal Oral Suspension in horses used for breeding purposes during pregnancy, or in lactating mares has not been evaluated. The safety of ReBalance Antiprotozoal Oral Suspension with concomitant therapies in horses has not been evaluated.
Related products
Doxycycline Capsules
| 823RX | 100 mg 50 ct | $18.99 | ||
| 895RX | 100 mg 500 ct | $149.99 |
Marquis Antiprotozoal Oral for Horses
| 1215RX ** | 1 ct | $362.49 | ||
| 429RX | 4 ct | $1,289.09 |
Metronidazole
| 183RX | 250 mg 250 ct | $24.99 | ||
| 592RX | 500 mg 100 ct | $25.49 | ||
| 673RX | 500 mg 500 ct | $67.99 |
Reviews
There are no reviews yet.